Service

Confidentiality

Reviews

Pricing

Contact

AI Manuscript Information Extraction Explained

By
5 Minutes Read

A manuscript lands in your inbox with 10 co-authors, 87 references, tracked changes from three rounds of review, and a deadline that was unrealistic two days ago. The problem usually is not writing alone. It is finding, validating, and structuring the information buried across sections, tables, citations, appendices, and reviewer comments. That is where AI manuscript information extraction starts to matter for medical writers, publication teams, and research groups.

For medical peeps, this is not a nice-to-have automation layer. It is a way to reduce the manual drag around pulling trial identifiers, endpoints, safety statements, author details, abbreviations, reference metadata, and submission-ready facts from dense scientific documents. Done well, it shortens repetitive work without lowering the bar on scientific rigor.

What AI manuscript information extraction actually does

At its core, AI manuscript information extraction means using AI to identify and pull structured information from an unstructured manuscript. A human reads a paper and instinctively knows where to find the primary endpoint, corresponding author, study design, or disclosure language. Software has to be taught to recognize those patterns.

In a medical and pharma setting, the useful outputs are rarely generic. Teams usually need very specific fields such as inclusion criteria, adverse events, dose regimens, confidence intervals, journal formatting details, or reference inconsistencies. Extracting those items manually can take longer than people admit, especially when the document set includes protocols, supplementary materials, PDFs, reviewer letters, and old draft versions.

The practical gain is not just speed. Structured extraction makes downstream work easier. Once data points are captured consistently, they can support literature review workflows, manuscript quality checks, reference verification, and internal review packs. That is much more valuable than simply asking a general AI tool to summarize a paper.

Why generic extraction often breaks in medical writing

A manuscript is not a simple document. It contains nuanced scientific claims, statistical notation, discipline-specific terminology, and context that changes the meaning of a sentence. A general-purpose AI system may detect headings and names reasonably well, but medical writing asks for more precision than that.

Take a sentence describing a secondary endpoint in a subgroup analysis. A generic model might lift the sentence but miss the fact that it is exploratory, not confirmatory. Or it may misread a table footnote that changes how an efficacy result should be interpreted. Those are not edge cases. They show up every day in publication and regulatory workflows.

This is why domain-specific extraction matters. The model needs to understand manuscript structure, biomedical language, reference behavior, and the kinds of fields medical teams actually care about. It also needs to work in environments where confidentiality is non-negotiable. If your manuscript includes unpublished data, sponsor-sensitive wording, or client-owned content, convenience alone is not a valid trade.

Where AI manuscript information extraction helps most

The strongest use cases tend to be repetitive, high-volume, and easy to verify by a human reviewer. Reference extraction is an obvious one. Pulling author names, journal titles, publication years, DOI details, and citation mismatches can absorb hours across a large manuscript. AI can surface that information quickly so the writer or editor can focus on corrections rather than hunting.

Another strong use case is study detail extraction. Medical writers often need to collect trial phase, sample size, treatment arms, endpoints, and key findings from one or several source documents. AI can pre-structure those fields, which is useful for literature matrices, evidence summaries, advisory board reports, and manuscript support documents.

It is also useful for editorial quality control. An extraction workflow can flag inconsistent abbreviations, conflicting numerical values across abstract and body text, missing disclosures, incomplete affiliations, or references cited in text but absent from the bibliography. AI does not replace editorial judgment here. It narrows the review field so humans spend time where it counts.

Another important use case is to automate reference packs. Medcomms teams and freelance medical writers almost always need to prepare a reference pack or refpack to show the correctness of their writing. It is an important step in the Medical Legal and Regulatory (MLR) review of pharmaceutical companies. Such refpack takes a few minutes to a few hours to complete. Not only can AI-based manuscript information extraction help to check the correctness, it can even prepare the full reference pack to reduce workload and assure correctness of medical writing and speed up MLR review.

AI manuscript information extraction in real workflows

In practice, this process works best when it fits the way teams already review documents. A writer uploads or inputs a manuscript, selects the information they want extracted, and receives a structured output for review. That output might be a table of references, a list of study characteristics, a set of inconsistencies, or a draft evidence summary.

The quality of the result depends on the document quality and the extraction goal. Clean source files with stable formatting usually produce better outputs than scanned PDFs or heavily annotated drafts. Short, tightly defined extraction tasks also perform better than broad requests like pull everything important from this manuscript. Specificity matters.

For that reason, the most effective systems are designed around actual publication and medical editing tasks rather than open-ended prompting. Your friendly CORTIX.io team approaches this as workflow support, not novelty AI. The point is to reduce manual burden in medical writing while preserving control over what gets accepted, revised, or rejected.

Why HiTM matters more than raw automation

This is one area where HiTM really earns its place. HiTM stands for human in the middle, and in medical writing it is not a cautious extra. It is the operating model that keeps extraction useful and safe. AI can identify likely data points, classify content, and draft structured outputs. Humans still confirm whether the extracted endpoint is the right one, whether a citation was mapped correctly, or whether a sentence was interpreted with the right scientific context.

A simple example is subtitle generation from meeting audio. AI can create a fast first pass, but a human check is what catches speaker overlap, technical terminology, and phrasing that should not be finalized as-is. The same principle applies to manuscripts. Extraction should accelerate review, not bypass it. For teams building reliable scientific workflows, HiTM - human in the middle - is the difference between assistance and risk. 

Confidentiality is part of the workflow, not a footnote

Many teams hesitate to use AI on manuscripts for a good reason. These documents may contain unpublished findings, confidential sponsor strategy, or regulated content. If an extraction tool cannot clearly address data handling, it creates friction before the workflow even starts.

That is why privacy and deployment options matter just as much as extraction accuracy. Some teams are comfortable with SaaS environments. Others need tighter control through MCP or on-premise installation. The right setup depends on your organization, your client obligations, and the sensitivity of the material.

For manuscript work in pharma and medical communications, confidentiality is not a branding line. It is a practical requirement that determines whether AI can be used at all.

What good results look like

The best outcome is not a perfect machine-read manuscript. It is a cleaner, faster editorial process or an enhanced MLR review. If AI manuscript information extraction saves a writer from manually compiling reference details and refpacks, helps an editor catch inconsistencies before submission, a medical affairs manager to approve a document in VEEVA Vault, or gives a publication team a structured head start on evidence mapping, it is doing the job.

You should also expect limits. Extraction can struggle with poorly formatted legacy files, image-heavy PDFs, unusual journal layouts (often intoduced to prevent AI scraping), and ambiguous phrasing. It may identify the right section but pull the wrong value if the source includes conflicting versions. In those cases, the human reviewer becomes even more important.

A useful benchmark is whether the tool reduces low-value effort without creating a verification burden that cancels out the time savings. If the output is easy to inspect and correct, adoption tends to be strong. If users spend too much time reformatting or second-guessing unclear output, trust drops quickly.

 

Picture of Stijn van den Borne

Stijn van den Borne

Stijn van den Borne is a co-founder of CORTiX Limited, the company behind CORTiX.io and Dub-Dub.ai. CORTiX.io is a privacy first platform creating AI-tools specifically geared towards medical communications agencies, medical affairs and marketing in medical devices and pharmaceutical industry, as well as freelance medical writers. CORTiX.io is currently testing the AI-tools using its parent company ['mediPr] for the validation of the medical writing toolbox. Stijn's work building AI tools for pharmaceutical and clinical research teams exposed a gap the market had consistently failed to fill: accurate, intuitive medical writing and transcription tools with genuine privacy guarantees and fair pay-as-you-go pricing. He writes about AI for medcomms, implementing AI in workflows, and the practical realities of building responsible AI tools for real-world use.

Author